BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Sanyou Bio and Yugong Bio Forge Strategic Alliance to Advance High-End Synthetic Molecular Enzymes

Sanyou Bio and Yugong Bio today announced the signing of a strategic cooperation agreement. This powerful alliance marks a significant step ...

November 12, 2025 | News

Samsung Epis Holdings Launches Epis NexLab to Advance Next-Generation Biotechnology Platforms

Samsung Epis Holdings Co., Ltd. announced the establishment of Epis NexLab Co., Ltd., a new subsidiary that will focus on the development o...

November 12, 2025 | News

OGT Launches SureSeq™ Myeloid MRD Plus NGS Panel to Enhance Detection of Residual Disease in AML

OGT announced the launch of a new next-generation sequencing (NGS) panel for Measurable Residual Disease (MRD) - the SureSeq™ Myeloid MRD Plus NGS Pa...

November 11, 2025 | News

Primrose Bio Launches Prima RNApols™ ExTend Cap AU to Enhance Self-Amplifying mRNA Vaccine Manufacturing

Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, announced the launch of Prima RNApols™ ...

November 11, 2025 | News

ERS Genomics Grants CRISPR/Cas9 Patent Access to Dyadic to Advance Animal-Free Protein and Enzyme Production

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology company producing precision-...

November 11, 2025 | News

Akeso Initiates First-in-Human Trial of Personalised mRNA Vaccine AK154 for Pancreatic Cancer

Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vacc...

November 11, 2025 | News

High-Throughput Vaccine Production: The Future of Scalable, Rapid Immunisation

Vaccines remain the cornerstone of infectious disease control, but traditional development pathways are slow and resource‐intensive. Modern chall...

November 10, 2025 | Analysis

Harbour BioMed and Evinova Partner to Drive AI-Enabled Biologics Development

Harbour BioMed ("HBM" or the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel anti...

November 10, 2025 | News

Eli Lilly Partners with SanegeneBio to Advance RNAi Therapies for Metabolic Diseases

-Companies will collaborate on RNAi research for metabolic disease targets SanegeneBio, a clinical-stage biotechnology company developing innov...

November 10, 2025 | News

Tenpoint Therapeutics and Zhaoke Ophthalmology Advance BRIMOCHOL™ PF Toward Global Market with NDA Filing in South Korea

Submission of New Drug Application (NDA) in South Korea by Zhaoke Ophthalmology Ltd.’s local partner, Kwangdong Pharmaceutical Co., Ltd., marks the...

November 07, 2025 | News

Samsung Bioepis Reaches Settlement with J&J on Stelara Biosimilar PYZCHIVA in Europe

Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Johnson & Johnson concerning the commercialization of PYZCHIVA®, a bio...

November 07, 2025 | News

CorrectSequence Therapeutics Achieves World’s First Gene-Editing Success in Hyperlipidaemia Treatment

CorrectSequence Therapeutics' CS-121 Completed Dosing of First Chylomicronemia Patient, Demonstrating Excellent Safety and Significant Efficacy On&n...

November 07, 2025 | News

Mölnlycke Establishes First Wound Care Manufacturing Site in China to Strengthen Local Production and Supply Chain Resilience

Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement of its new wound car...

November 06, 2025 | News

Ailux and Eli Lilly Forge $345 Million AI-Driven Collaboration to Accelerate Bispecific Antibody Discovery

Ailux, an innovator in AI-powered biologics and a wholly owned subsidiary of XtalPi (2228.HK), a global leader in AI drug discovery, today announced a stra...

November 06, 2025 | News

Stay Connected